0001004878-18-000071.txt : 20180404
0001004878-18-000071.hdr.sgml : 20180404
20180404163754
ACCESSION NUMBER: 0001004878-18-000071
CONFORMED SUBMISSION TYPE: 424B3
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20180404
DATE AS OF CHANGE: 20180404
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: 424B3
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-186103
FILM NUMBER: 18737707
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
424B3
1
prosuppswrt186103april-18.txt
PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(3)
(To Prospectus Supplements dated December Registration No. 333-186103
19 and December 26, 2013)
CEL-SCI CORPORATION
Series S Warrants
On April 3, 2018 the exercise price of the Company's outstanding Series S
warrants (CUSIP number 150837177), that are publicly traded under the symbol
"CVM WS" on the NYSE American, was changed to $1.75 per share until June 11,
2018. After this date, the exercise price will revert back to $31.25 per share
of common stock. As a result of the reverse stock split which became effective
on the NYSE American on June 15, 2017, 25 Series S warrants are required to
purchase one share of common stock. The Series S warrants expire on October 11,
2018.
Prospectus Supplement dated April 3, 2018